Related Experiment Videos
Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways
1Department of Neurology, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA. bhatnr@musc.edu
Abstract:
Non-replicating adenovirus vectors (AdV) represent effective tools for long-term gene expression in the central nervous system (CNS), but they also elicit inflammation. The cellular and molecular mechanisms of such a response are not understood. In the present study, we show that infection with AdV causes activation of microglial cells, the key cells involved in inflammatory and immune-regulatory functions in the brain. Exposure of cultured rat brain microglia to AdV resulted in an induced production of nitric oxide (NO) and the expression of inducible nitric oxide synthase (iNOS) and the pro-inflammatory cytokine, TNFalpha. The roles of signal transduction pathways believed to be involved in microglial activation in particular, mitogen-activated protein kinases (MAPKs) and nuclear factor kappaB (NFkappaB) were explored by determining their activation in response to AdV infection and by testing the effects of specific pharmacological inhibitors. It was found that AdV strongly activates extracellular signal-regulated kinase (ERK) and to a lesser extent, p38 MAPK but not NFkappaB. Addition of the kinase inhibitor, i.e. PD98059 (specific for the ERK pathway), inhibits and, in combination with the p38 MAPK inhibitor, SB203580, drastically suppresses AdV-induced expression of iNOS and TNFalpha. The results suggest that AdV uses cellular signal transduction machinery, in particular the MAPK pathways, to elicit microglial activation and that increased production by these cells of inflammatory mediators may primarily contribute to CNS inflammatory responses commonly seen in models of gene therapy using AdV vectors.
Insights
Non-replicating adenovirus vectors (AdV) activate brain microglial cells, driving inflammation via the ERK and p38 MAPK pathways. This AdV-induced microglial activation contributes to central nervous system inflammation in gene therapy.
Area of Science:
- Neuroscience
- Immunology
- Gene Therapy
Background:
- Non-replicating adenovirus vectors (AdV) are effective for long-term gene expression in the central nervous system (CNS).
- AdV use in gene therapy can elicit CNS inflammation, but the underlying mechanisms are poorly understood.
Purpose of the Study:
- To investigate the cellular and molecular mechanisms of AdV-induced inflammation in the CNS.
- To determine the role of microglial activation and specific signaling pathways in AdV-mediated inflammatory responses.
Main Methods:
- Cultured rat brain microglia were exposed to AdV.
- Nitric oxide (NO), inducible nitric oxide synthase (iNOS), and TNFalpha production were measured.
- Activation of mitogen-activated protein kinases (MAPKs) and nuclear factor kappaB (NFkappaB) was assessed.
- Pharmacological inhibitors of ERK (PD98059) and p38 MAPK (SB203580) were used.
Main Results:
- AdV infection activated microglia, increasing NO, iNOS, and TNFalpha production.
- AdV strongly activated extracellular signal-regulated kinase (ERK) and moderately activated p38 MAPK, but not NFkappaB.
- Inhibition of ERK and p38 MAPK pathways significantly suppressed AdV-induced iNOS and TNFalpha expression.
Conclusions:
- AdV utilizes MAPK signaling pathways, particularly ERK, to induce microglial activation.
- AdV-induced microglial inflammatory mediator production is a key contributor to CNS inflammation in gene therapy models.